New England Biolabs® spotlights multiomic profiling of cell-free DNA (cfDNA) and cell-free RNA (cfRNA) at the AMP 2026 Annual Meeting & Expo in Seattle, Washington

Markets PR Newswire By PR Newswire 06 Nov 2026 15:00 1 min read
New England Biolabs® spotlights multiomic profiling of cell-free DNA (cfDNA) and cell-free RNA (cfRNA) at the AMP 2026 Annual Meeting & Expo in Seattle, Washington

Leveraging over 50 years of expertise in enzymology, NEB® shares insights on reagents and workflows for molecular diagnostics, including cfDNA & cfRNA analysis, enzymatic methylation profiling, and high-fidelity PCR. IPSWICH, Mass., Nov. 6, 2026 /PRNewswire/ -- New England Biolabs (NEB),...

Covered in this story

Call it yourself

No calls on $DNA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Ginkgo Bioworks Holdings Inc Class →
Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.